NO2252275T3 - - Google Patents
Info
- Publication number
- NO2252275T3 NO2252275T3 NO09709833A NO09709833A NO2252275T3 NO 2252275 T3 NO2252275 T3 NO 2252275T3 NO 09709833 A NO09709833 A NO 09709833A NO 09709833 A NO09709833 A NO 09709833A NO 2252275 T3 NO2252275 T3 NO 2252275T3
- Authority
- NO
- Norway
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Otolaryngology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2821808P | 2008-02-13 | 2008-02-13 | |
PCT/US2009/034162 WO2009103035A2 (en) | 2008-02-13 | 2009-02-13 | Templated open flocs of anisotropic particles for enhanced pulmonary delivery |
Publications (1)
Publication Number | Publication Date |
---|---|
NO2252275T3 true NO2252275T3 (pt) | 2018-04-28 |
Family
ID=40955349
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO09709833A NO2252275T3 (pt) | 2008-02-13 | 2009-02-13 |
Country Status (7)
Country | Link |
---|---|
US (6) | US20090208582A1 (pt) |
EP (1) | EP2252275B1 (pt) |
AU (1) | AU2009214443B2 (pt) |
CA (1) | CA2723314C (pt) |
DK (1) | DK2252275T3 (pt) |
NO (1) | NO2252275T3 (pt) |
WO (1) | WO2009103035A2 (pt) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2723314C (en) * | 2008-02-13 | 2017-01-10 | The Board Of Regents, The University Of Texas System | Templated open flocs of anisotropic particles for enhanced pulmonary delivery |
PT2410981T (pt) | 2009-03-26 | 2017-05-25 | Pulmatrix Inc | Formulações em pó seco e métodos para tratar doenças pulmonares |
US8506799B2 (en) * | 2009-09-09 | 2013-08-13 | ClearCorp | Suspended particle characterization system for a water processing facility |
US9248110B2 (en) | 2010-03-18 | 2016-02-02 | Steven Lehrer | Compositions and methods of treating and preventing lung cancer and lymphangioleiomyomatosis |
WO2011115988A1 (en) * | 2010-03-18 | 2011-09-22 | Steven Lehrer | Compositions and methods of treating and preventing lung cancer |
US9228785B2 (en) | 2010-05-04 | 2016-01-05 | Alexander Poltorak | Fractal heat transfer device |
WO2012030647A1 (en) | 2010-08-30 | 2012-03-08 | Pulmatrix, Inc. | Treatment of cystic fibrosis using calcium lactate, leucine and sodium chloride in a respiraple dry powder |
US9061352B2 (en) | 2010-08-30 | 2015-06-23 | Pulmatrix, Inc. | Dry powder formulations and methods for treating pulmonary diseases |
IL286573B (en) | 2010-09-29 | 2022-08-01 | Pulmatrix Operating Co Inc | Monovalent metallic cation dry powders for inhalation |
WO2012050945A1 (en) | 2010-09-29 | 2012-04-19 | Pulmatrix, Inc. | Cationic dry powders |
WO2014186754A2 (en) | 2013-05-16 | 2014-11-20 | Board Of Regents The University Of Texas System | Dry solid aluminum adjuvant-containing vaccines and related methods thereof |
CN104274426A (zh) * | 2013-07-03 | 2015-01-14 | 陆克塞纳医药公司 | 昂丹司琼细粉、昂丹司琼气溶胶组合物及其用途 |
CN104274427A (zh) * | 2013-07-03 | 2015-01-14 | 陆克塞纳医药公司 | 格拉司琼气溶胶组合物及其用途 |
EP3738592B1 (en) * | 2013-10-08 | 2022-01-26 | AI Therapeutics, Inc. | Rapamycin for the treatment of lymphangioleiomyomatosis |
DK3107548T3 (da) | 2014-02-20 | 2022-07-18 | Otitopic Inc | Tørpulverformuleringer til inhalation |
EP4218742A1 (en) | 2014-04-04 | 2023-08-02 | AI Therapeutics, Inc. | An inhalable rapamycin formulation for treating age-related conditions |
EP3179986B1 (en) | 2014-07-31 | 2023-03-15 | Vectura Inc. | Dry powder formulations for inhalation |
AU2015330905B2 (en) | 2014-10-07 | 2021-02-25 | AI Therapeutics, Inc. | An inhalable rapamycin formulation for the treatment of pulmonary hypertension |
CN107666903B (zh) * | 2015-05-01 | 2021-08-20 | 得克萨斯州大学系统董事会 | 多药脆性基质组合物 |
PE20181295A1 (es) | 2015-09-01 | 2018-08-07 | First Wave Bio Inc | Metodos y composiciones para tratar afecciones asociadas a una respuesta inflamatoria anomala |
US10550019B2 (en) | 2016-04-08 | 2020-02-04 | OptikTechnik LLC | Automated dosing system and method with light profiling for wastewater filtration system |
WO2018013668A1 (en) | 2016-07-12 | 2018-01-18 | Alexander Poltorak | System and method for maintaining efficiency of a heat sink |
CA3039485A1 (en) | 2016-10-14 | 2018-04-19 | Pulmatrix Operating Company, Inc. | Antifungal dry powders |
US11918646B2 (en) | 2017-12-11 | 2024-03-05 | Board Of Regents, The University Of Texas System | Dry adjuvanted immune stimulating compositions and use thereof for mucosal administration |
WO2019204568A1 (en) * | 2018-04-20 | 2019-10-24 | Board Of Regents, The University Of Texas System | Apparatus and methods for characterizing plume geometry |
US10980756B1 (en) | 2020-03-16 | 2021-04-20 | First Wave Bio, Inc. | Methods of treatment |
WO2021188564A1 (en) | 2020-03-16 | 2021-09-23 | First Wave Bio, Inc. | Methods of treating covid-19 with a niclosamide compound |
EP4125923A1 (en) | 2020-04-01 | 2023-02-08 | Board of Regents, The University of Texas System | Pharmaceutical compositions of niclosamide |
CN116710118A (zh) | 2020-05-26 | 2023-09-05 | 格兰达利斯有限公司 | 病毒性呼吸道感染的治疗方法 |
WO2022055817A1 (en) | 2020-09-09 | 2022-03-17 | Gradalis, Inc. | Composition formulated into inhalable dosage forms for the treatment of lung|tumors |
EP4337173A1 (en) | 2021-05-12 | 2024-03-20 | TFF Pharmaceuticals, Inc. | Dry powder formulations of tacrolimus for administration by inhalation once daily (qd) |
WO2023034795A1 (en) * | 2021-08-30 | 2023-03-09 | Board Of Regents, The University Of Texas System | Monoclonal antibody dry powders |
US20230112800A1 (en) | 2021-08-31 | 2023-04-13 | Board Of Regents, The University Of Texas System | Delayed release niclosamide formulation |
WO2024059819A2 (en) | 2022-09-15 | 2024-03-21 | Tff Pharmaceuticals, Inc. | Compositions of cannabinoids for delivery by inhalation |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9501841D0 (en) | 1995-01-31 | 1995-03-22 | Co Ordinated Drug Dev | Improvements in and relating to carrier particles for use in dry powder inhalers |
JPH1112197A (ja) | 1997-06-18 | 1999-01-19 | Cosmo Sogo Kenkyusho:Kk | 悪性腫瘍診断剤及び治療剤 |
US6565885B1 (en) * | 1997-09-29 | 2003-05-20 | Inhale Therapeutic Systems, Inc. | Methods of spray drying pharmaceutical compositions |
US6284282B1 (en) * | 1998-04-29 | 2001-09-04 | Genentech, Inc. | Method of spray freeze drying proteins for pharmaceutical administration |
US6294192B1 (en) * | 1999-02-26 | 2001-09-25 | Lipocine, Inc. | Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents |
US6585957B1 (en) * | 2000-01-25 | 2003-07-01 | Aeropharm Technology Incorporated | Medicinal aerosol formulation |
TWI224515B (en) | 2000-06-23 | 2004-12-01 | Norton Healthcare Ltd | Pre-metered dose magazine for breath-actuated dry powder inhaler |
JP2003146523A (ja) | 2001-11-15 | 2003-05-21 | Canon Inc | 画像形成装置 |
CA2483218C (en) * | 2002-04-25 | 2012-07-10 | Nektar Therapeutics Uk Ltd | Particulate materials |
GB0216562D0 (en) * | 2002-04-25 | 2002-08-28 | Bradford Particle Design Ltd | Particulate materials |
CN1694689A (zh) * | 2002-09-30 | 2005-11-09 | 阿库斯菲尔公司 | 供吸入的缓释多孔微粒 |
JP2006513235A (ja) * | 2002-12-31 | 2006-04-20 | ネクター セラピューティクス | 真菌感染症療法のためのエアゾール化可能な医薬製剤 |
US9175906B2 (en) | 2003-01-15 | 2015-11-03 | Board Of Regents, The University Of Texas System | Drug particles from freezing onto a surface |
JP2007505136A (ja) * | 2003-09-10 | 2007-03-08 | マツプ・フアーマシユーテイカルズ・インコーポレーテツド | ジヒドロエルゴタミンを肺吸入により体循環に送達するためのエアゾール製剤 |
US9061027B2 (en) | 2004-08-27 | 2015-06-23 | Board Of Regents, The University Of Texas System | Enhanced delivery of drug compositions to treat life threatening infections |
MX2009012782A (es) * | 2007-05-25 | 2010-03-04 | Univ British Columbia | Formulaciones para administracion oral de agentes terapeuticos y metodos relacionados. |
CA2723314C (en) * | 2008-02-13 | 2017-01-10 | The Board Of Regents, The University Of Texas System | Templated open flocs of anisotropic particles for enhanced pulmonary delivery |
-
2009
- 2009-02-13 CA CA2723314A patent/CA2723314C/en active Active
- 2009-02-13 DK DK09709833.9T patent/DK2252275T3/en active
- 2009-02-13 US US12/371,573 patent/US20090208582A1/en active Pending
- 2009-02-13 WO PCT/US2009/034162 patent/WO2009103035A2/en active Application Filing
- 2009-02-13 NO NO09709833A patent/NO2252275T3/no unknown
- 2009-02-13 AU AU2009214443A patent/AU2009214443B2/en active Active
- 2009-02-13 EP EP09709833.9A patent/EP2252275B1/en active Active
-
2010
- 2010-05-12 US US12/778,795 patent/US10092512B2/en active Active
-
2018
- 2018-08-29 US US16/115,888 patent/US10434062B2/en active Active
-
2019
- 2019-08-29 US US16/555,165 patent/US10660850B2/en active Active
-
2020
- 2020-04-03 US US16/839,957 patent/US11364197B2/en active Active
-
2022
- 2022-05-17 US US17/746,915 patent/US12029816B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US20210007971A1 (en) | 2021-01-14 |
EP2252275B1 (en) | 2017-11-29 |
US11364197B2 (en) | 2022-06-21 |
US10434062B2 (en) | 2019-10-08 |
EP2252275A2 (en) | 2010-11-24 |
WO2009103035A2 (en) | 2009-08-20 |
AU2009214443B2 (en) | 2013-10-10 |
US20220354778A1 (en) | 2022-11-10 |
CA2723314C (en) | 2017-01-10 |
US10660850B2 (en) | 2020-05-26 |
EP2252275A4 (en) | 2013-11-06 |
CA2723314A1 (en) | 2009-08-20 |
DK2252275T3 (en) | 2018-03-05 |
US20100221343A1 (en) | 2010-09-02 |
US10092512B2 (en) | 2018-10-09 |
WO2009103035A3 (en) | 2009-11-12 |
US20190117557A1 (en) | 2019-04-25 |
US20090208582A1 (en) | 2009-08-20 |
US12029816B2 (en) | 2024-07-09 |
US20200069572A1 (en) | 2020-03-05 |
AU2009214443A1 (en) | 2009-08-20 |